Colgate-Palmolive opened the Volpe Clinical Research Center in Piscataway, which it hopes will accelerate development of the company’s cutting-edge technology and product formulas.
During the opening ceremony held on June 1 and hosted at Colgate’s Global Technology Center, festivities opened with remarks from Chairman, CEO and President Noel Wallace; Chief Clinical Officer Maria Ryan; and Chief Technology Officer Pat Verduin.
Guests from Colgate’s longstanding partners at Rutgers University, the American Dental Association and the New Jersey Dental Association were also in attendance.
The ceremony included a presentation of a plaque featuring a replica of a sculpture of the late Anthony Volpe, the center’s namesake and company’s formative leader for more than 50 years, and a tour of the new clinical facility for guests.
The Volpe Center will allow Colgate to further its commitment to bring consumers the most efficacious products based on clinical research by leveraging a unique cross-team structure that brings together Colgate’s research & development team, clinical team, innovation team and consumer insights specialists.
The center will empower Colgate to more easily test and learn about the benefits of new formulations and devices, gain immediate feedback on prototypes and receive direct consumer insights from study participants.
In addition to advancing oral care, Colgate researchers will also use the new facility to support innovation for the company’s skin health business.
